Modeling Filovirus Infection of and Trafficking through Skin
模拟丝状病毒通过皮肤的感染和贩运
基本信息
- 批准号:9751755
- 负责人:
- 金额:$ 76.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAfricaAnimal ModelAnimalsAntigen-Presenting CellsAntiviral TherapyApicalAutopsyBathingBiologicalCell Surface ReceptorsCellsDermalDermisDisease OutbreaksEbola virusEpidemicEpidermisEventFamilyFibroblastsFiloviridae InfectionsFilovirusHumanIndividualInfectionInfectious Skin DiseasesInterruptionLesionMacacaMeasuresMediatingModalityModelingMusPalliative CarePathway interactionsPatientsPetechiaePopulationPredispositionProductionPropertyPublic HealthReportingResearchRouteSamplingSatellite VirusesSkinSourceSupporting CellSurfaceTestingTherapeuticTimeVaccinesViral AntigensViral Load resultViral load measurementViremiaVirionVirusVirus Diseasescell typehuman tissueimprovedin vivoinhibitor/antagonistkeratinizationkeratinocytemortalitynonhuman primatepathogenpublic health prioritiesreceptorsuccesstraffickingtransmission processuptakeviral transmission
项目摘要
Abstract:
Filoviruses such as Ebola virus (EBOV) are found on the skin's surface at late times of infection
when viremia is high. Evidence indicates that skin-associated virus is an important source of
virus transmitted to others. Yet, how virus arrives at the surface is not well understood. Our
preliminary studies suggest that EBOV can traffic to the surface of the skin by infecting both
dermal and epidermal cell populations within the skin and that this route of virus delivery to the
skin's surface is important in vivo. Yet, which cells within the skin support filovirus replication
and are principally responsible for virus load are unknown. Here, we seek to understand EBOV
interactions with skin as it egresses from the body. We will also evaluate if EBOV is able to
enter through the intact or abraded skin surface. We hypothesize that direct infection of cells
within the skin serves as an important route of EBOV transmission. To examine this, we will test
the following aims. Purified primary skin cells (e.g. keratinocytes, fibroblasts, and antigen
presenting cells) will be examined for their support of EBOV infection and we will determine if
these same populations are infected in skin explants. Further, we will determine if known cell
surface receptors are expressed in permissive skin cells and explants and if inhibition of virus
interactions with those receptors blocks EBOV infection. We will also assess the timing of skin
involvement in EBOV infection in vivo in mice and in macaques. At the completion of these
important studies, an understanding of EBOV interactions with skin will be developed and a new
model platform will be established for studying filovirus infections of highly relevant human
tissue.
抽象的:
在感染后期,在皮肤表面上发现了诸如埃博拉病毒(EBOV)之类的丝病毒
当病毒血症高。证据表明皮肤相关病毒是
病毒传播给他人。然而,病毒如何到达表面尚不清楚。我们的
初步研究表明,EBOV可以通过感染两个
皮肤中的皮肤和表皮细胞群体,这种病毒递送到
皮肤的表面在体内很重要。但是,哪些细胞在皮肤中支持丝状病毒复制
并且主要负责病毒负荷是未知的。在这里,我们试图了解Ebov
与皮肤相互作用时,它会从体内流出。我们还将评估Ebov是否能够
通过完整或磨损的皮肤表面输入。我们假设细胞的直接感染
皮肤内是EBOV传播的重要途径。为了检查一下,我们将测试
以下目标。纯化的原代皮肤细胞(例如角质形成细胞,成纤维细胞和抗原
呈现细胞)将检查其对EBOV感染的支持,我们将确定是否确定
这些相同的种群在皮肤外植体中被感染。此外,我们将确定是否已知细胞
表面受体在允许的皮肤细胞和外植体中表达,以及病毒的抑制
与这些受体的相互作用阻碍了EBOV感染。我们还将评估皮肤的时间
参与小鼠和猕猴的体内EBOV感染。完成这些
重要的研究,将了解EBOV与皮肤相互作用的理解,并有一个新的
将建立模型平台来研究高度相关的人类的丝状病毒感染
组织。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wendy Jean Maury其他文献
Wendy Jean Maury的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wendy Jean Maury', 18)}}的其他基金
Elucidating mechanisms of interferon gamma that protect against Ebola virus infection
阐明干扰素γ预防埃博拉病毒感染的机制
- 批准号:
10539126 - 财政年份:2022
- 资助金额:
$ 76.74万 - 项目类别:
Elucidating mechanisms of interferon gamma that protect against Ebola virus infection
阐明干扰素γ预防埃博拉病毒感染的机制
- 批准号:
10696250 - 财政年份:2022
- 资助金额:
$ 76.74万 - 项目类别:
Modeling Filovirus Infection of and Trafficking through Skin
模拟丝状病毒通过皮肤的感染和贩运
- 批准号:
10212949 - 财政年份:2018
- 资助金额:
$ 76.74万 - 项目类别:
Modeling Filovirus Infection of and Trafficking through Skin
模拟丝状病毒通过皮肤的感染和贩运
- 批准号:
9977938 - 财政年份:2018
- 资助金额:
$ 76.74万 - 项目类别:
Using miRNAs to elucidate the cellular sources of HIV-1
使用 miRNA 阐明 HIV-1 的细胞来源
- 批准号:
8789293 - 财政年份:2014
- 资助金额:
$ 76.74万 - 项目类别:
Filoviral glycoprotein/cellular protein interactions
丝状病毒糖蛋白/细胞蛋白相互作用
- 批准号:
8645588 - 财政年份:2010
- 资助金额:
$ 76.74万 - 项目类别:
Filoviral glycoprotein/cellular protein interactions
丝状病毒糖蛋白/细胞蛋白相互作用
- 批准号:
8004313 - 财政年份:2010
- 资助金额:
$ 76.74万 - 项目类别:
Filoviral glycoprotein/cellular protein interactions
丝状病毒糖蛋白/细胞蛋白相互作用
- 批准号:
8260870 - 财政年份:2010
- 资助金额:
$ 76.74万 - 项目类别:
Filoviral glycoprotein/cellular protein interactions
丝状病毒糖蛋白/细胞蛋白相互作用
- 批准号:
8460562 - 财政年份:2010
- 资助金额:
$ 76.74万 - 项目类别:
相似国自然基金
基于非洲猪瘟病毒pS273R蛋白泛素-蛋白酶体降解途径阻抑机制理性设计其特异性蛋白水解靶向嵌合体的研究
- 批准号:32373044
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
非洲猪瘟病毒B475L蛋白靶向LMP2抑制抗原递呈的分子机制
- 批准号:32302894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非洲猪瘟病毒pS273R通过切割G3BP1调控宿主应激颗粒形成的机制
- 批准号:32302893
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗体依赖性增强效应介导非洲猪瘟病毒致病的分子机制
- 批准号:32373024
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
非洲爪蟾IV型干扰素IFN-upsilon在不同发育阶段的抗病毒功能研究
- 批准号:32303043
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of antibody drug conjugates as pan-filo antivirals
开发作为泛型抗病毒药物的抗体药物偶联物
- 批准号:
10759731 - 财政年份:2023
- 资助金额:
$ 76.74万 - 项目类别:
The Protective and Pathologic Features of the EVD Survivor Immune System
埃博拉病毒病幸存者免疫系统的保护和病理特征
- 批准号:
10639583 - 财政年份:2023
- 资助金额:
$ 76.74万 - 项目类别:
Pharmacokinetic and pharmacodynamic relationships for antibacterial treatment of shigellosis
抗菌治疗志贺氏菌病的药代动力学和药效学关系
- 批准号:
10656116 - 财政年份:2023
- 资助金额:
$ 76.74万 - 项目类别:
Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposure
整合人类和非人类灵长类动物数据,以了解在面对先前的疟疾暴露时获得红细胞前免疫力
- 批准号:
10343399 - 财政年份:2022
- 资助金额:
$ 76.74万 - 项目类别:
Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposure
整合人类和非人类灵长类动物数据,以了解在面对先前的疟疾暴露时获得红细胞前免疫力
- 批准号:
10570273 - 财政年份:2022
- 资助金额:
$ 76.74万 - 项目类别: